loadpatents
name:-0.0027270317077637
name:-0.019865989685059
name:-0.00064182281494141
Heimburger; Norbert Patent Filings

Heimburger; Norbert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Heimburger; Norbert.The latest application filed is for "c1-inh as a drug for treating viruses pathogenic to humans".

Company Profile
0.21.1
  • Heimburger; Norbert - Marburg DE
  • Heimburger; Norbert - Marburg/Lahn DE
  • Heimburger; Norbert - Marburg an der Lahn DE
  • Heimburger; Norbert - Frankfurt am Main DE
  • Heimburger; Norbert - Marbach near Marburg/Lahn DT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
C1-inh as a drug for treating viruses pathogenic to humans
App 20060233776 - Heimburger; Norbert ;   et al.
2006-10-19
One-component tissue adhesive and a process for the production thereof
Grant 6,500,427 - Heimburger , et al. December 31, 2
2002-12-31
Pasteurized, purified von Willebrand factor concentrate and a process for the preparation thereof
Grant 6,239,261 - Heimburger , et al. May 29, 2
2001-05-29
One-component tissue adhesive and a process for the production thereof
Grant 5,407,671 - Heimburger , et al. April 18, 1
1995-04-18
Process for removing toxins from protein solutions
Grant 5,136,026 - Romisch , et al. August 4, 1
1992-08-04
Agent for the therapy of factor VIII-resistant hemophilia A, and a process for the preparation thereof
Grant 5,091,363 - Heimburger , et al. February 25, 1
1992-02-25
Method for the determination of the activity of serine proteases or serine protease inhibitors
Grant 5,057,414 - Stief , et al. October 15, 1
1991-10-15
Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
Grant 5,043,428 - Heimburger , et al. August 27, 1
1991-08-27
Pasteurized human fibrinogen (HF), a process for its preparation, and its use
Grant 4,960,757 - Kumpe , et al. October 2, 1
1990-10-02
Process for the preparation of the C1 inactivator
Grant 4,915,945 - Pelzer , et al. April 10, 1
1990-04-10
Readily dissolvable lyophilized fibrinogen formulation
Grant 4,650,678 - Fuhge , et al. March 17, 1
1987-03-17
Process for the pasteurization of human residual plasma
Grant 4,579,735 - Heimburger , et al. April 1, 1
1986-04-01
Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby
Grant 4,562,072 - Heimburger , et al. December 31, 1
1985-12-31
Method for rendering factors IX and X hepatitis-safe with calcium ions
Grant 4,405,603 - Schwinn , et al. September 20, 1
1983-09-20
Method for rendering factors II and VII hepatitis-safe with a chelating agent
Grant 4,404,187 - Schwinn , et al. September 13, 1
1983-09-13
Collagen solution, process for its manufacture and its use
Grant 4,331,766 - Becker , et al. May 25, 1
1982-05-25
Process for preparing the third component of the complement from human blood plasma
Grant 4,308,204 - Becker , et al. December 29, 1
1981-12-29
Blood coagulation factors and process for their manufacture
Grant 4,297,344 - Schwinn , et al. October 27, 1
1981-10-27
Method for the treatment of thromboembolism
Grant 4,178,368 - Heimburger , et al. December 11, 1
1979-12-11
Antihemophilic agent and process for its manufacture
Grant 4,067,964 - Schwinn , et al. January 10, 1
1978-01-10
Stable blood plasma, process for preparing it and its use as comparative plasma in coagulation tests
Grant 4,056,484 - Heimburger , et al. November 1, 1
1977-11-01
Process For The Isolation Of Native, Highly Purified Plasminogen
Grant 3,732,146 - Heimburger May 8, 1
1973-05-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed